Home › Funds › Lunate Capital Ltd › NMRA
Lunate Capital Ltd position in NMRA
NEUMORA THERAPEUTICS INC. · Health Care
Lunate Capital Ltd reported holding 2,124,143 shares of NMRA (NEUMORA THERAPEUTICS INC.) in its Q3 2026 13F filing — a position valued at US$1.3M, representing 0.18% of its reported portfolio and ranking #13 among its reported holdings. Lunate Capital Ltd has disclosed NMRA holdings in 7 of the last 7 reported quarters, going back to Q1 2025.
Last updated: 2026-11-05 · Source: SEC EDGAR Form 13F-HR
How Lunate Capital Ltd's NMRA position evolved
Lunate Capital Ltd first disclosed a stake in NMRA in Q1 2025 at 2,124,143 shares (US$2.1M). The position peaked in Q1 2026 at 2,124,143 shares, worth US$4.1M. Across 7 filings, Lunate Capital Ltd held the position steady without any share-count change. The most recent filing (Q3 2026) shows 2,124,143 shares valued at US$1.3M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 2.12M | $2.12M | New |
| Q2 2025 | 2.12M | $1.56M | Hold |
| Q3 2025 | 2.12M | $3.87M | Hold |
| Q4 2025 | 2.12M | $3.80M | Hold |
| Q1 2026 | 2.12M | $4.14M | Hold |
| Q2 2026 | 2.12M | $3.61M | Hold |
| Q3 2026 | 2.12M | $1.27M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About NMRA and 13F data
NMRA (NEUMORA THERAPEUTICS INC.) is a Health Care company. 22 other funds we track also report a position in NMRA — the largest reported positions include SOFTBANK GROUP CORP. (US$10.4M), MIC Capital Management UK LLP (US$7.6M), WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST (US$5.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding NMRA
- SOFTBANK GROUP CORP. 6.09M sh · $10.35M · Q2 2026
- MIC Capital Management UK LLP 4.46M sh · $7.58M · Q2 2026
- WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST 3.31M sh · $5.63M · Q2 2026
- ICONIQ Capital, LLC 2.56M sh · $4.35M · Q2 2026
- Boxer Capital Management, LLC 2.00M sh · $3.40M · Q2 2026
- JOHNSON & JOHNSON 1.85M sh · $3.14M · Q2 2026
More on Lunate Capital Ltd
FAQ
How long has Lunate Capital Ltd held NMRA?
Lunate Capital Ltd has disclosed NMRA holdings in 7 of the last 7 reported quarters, going back to Q1 2025.
What is Lunate Capital Ltd's current position in NMRA?
As of Q3 2026, Lunate Capital Ltd holds 2.12M shares of NMRA (NEUMORA THERAPEUTICS INC.), valued at $1.27M, representing 0.18% of its reported portfolio and ranking #13.
Has Lunate Capital Ltd been buying or selling NMRA?
In the latest 13F filing (Q3 2026), Lunate Capital Ltd held unchanged its position in NMRA. The position peaked in Q1 2026 at 2.12M shares.
Which other funds hold NMRA?
Other major institutional holders of NMRA include SOFTBANK GROUP CORP., MIC Capital Management UK LLP, WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST, among 22 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.